Nonetheless, the inflammatory modulation that comes with HCV increases the risk of DLBCL (OR = 2.33) [7], CLL/SLL (2.08) [10], MZL (3.04) [12], and LPL (2.70) [8]. This evidence concerns the gene LPL and B-cell chronic lymphocytic leukemia.